CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia2018 · 5,749 citations
2. 2Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia2014 · 5,461 citations
3. 3Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia2012 · 585 citations
4. 4On CAR-Ts, decentralized in-house models, and the hospital exception. Routes for sustainable access to innovative therapies2022 · 9 citations
5. 5Selective Immunophenotyping for Diagnosis of B-cell Neoplasms2012 · 57 citations